Get Live Data

The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Reneuron Share Price
  4. Reneuron Share Regulatory News
  5. Price Monitoring Extension

Pin to quick picksReneuron Regulatory News (RENE)

Reneuron Information
  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

26 Apr 2019 16:35

RNS Number : 3033X
ReNeuron Group plc
26 April 2019
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PMELLFVESEIRFIA
34567891011
Date   Source Headline
6th Sep 201711:15 amRNSResult of AGM
6th Sep 20177:00 amRNSAGM Trading Update
1st Sep 20177:00 amRNSNon-executive Director Appointment
1st Sep 20177:00 amRNSBlock Listing Review and TVR
7th Aug 20173:04 pmRNSPosting of Annual Report and Notice of AGM
4th Aug 20174:40 pmRNSSecond Price Monitoring Extn
4th Aug 20174:35 pmRNSPrice Monitoring Extension
25th Jul 20177:00 amRNSAppointment of joint broker
19th Jul 20177:00 amRNSBoard change
29th Jun 20177:00 amRNSPreliminary Results
19th Jun 20177:00 amRNSFDA approves cryopreserved hRPC formulation
8th Jun 20177:00 amRNSNotification of Preliminary Results
5th Jun 20177:00 amRNSPositive FDA feedback on proposed Phase III study
18th May 20177:00 amRNSPresents positive exosome data at major conference
11th May 20177:00 amRNSAwarded major UK cell therapy manufacturing grant
5th May 20177:00 amRNSPresents new exosome data at major conference
21st Apr 20177:01 amRNSUpdate on clinical strategy in stroke disability
21st Apr 20177:00 amRNSUpdate on progress in ophthalmology programmes
1st Mar 20177:00 amRNSBlock Listing Review and Total Voting Rights
15th Feb 20177:00 amRNSReNeuron featured in BBC documentary
7th Feb 201712:32 pmRNSDirector Share Purchase
14th Dec 201612:15 pmRNSDirector Share Purchase
5th Dec 20167:00 amRNSReports Positive Results in Phase II Stroke Trial
5th Dec 20167:00 amRNSInterim Results
14th Nov 20167:00 amRNSNotification of Interim Results
5th Oct 20162:30 pmRNSNotification of Major Interest in Shares
22nd Sep 20161:00 pmRNSBlock Listing Review and Total Voting Rights
6th Sep 201612:00 pmRNSResult of AGM
6th Sep 20167:00 amRNSAGM Trading Update
5th Aug 20164:35 pmRNSPosting of Annual Report and Notice of AGM
4th Aug 20167:00 amRNSStroke clinical data published in The Lancet
22nd Jul 20167:00 amRNSPublication of positive pre-clinical retinal data
20th Jul 20162:31 pmRNSDirectors' Interest in Shares and Share Options
7th Jul 20167:00 amRNSPreliminary Results
14th Jun 20167:00 amRNSNotification of Preliminary Results
13th Jun 20167:00 amRNSPatient recruitment completed in stroke trial
9th Jun 20167:01 amRNSPursues brain cancer with exosome platform
8th Jun 20167:00 amRNSRetinitis pigmentosa update & Notice of KOL event
31st May 201612:45 pmRNSChange of Adviser
15th Mar 20167:00 amRNSFirst Patient Treated in RP Clinical Trial
23rd Feb 20167:00 amRNSReNeuron Relocates to South Wales
17th Feb 20164:57 pmRNSDirector's Dealings
3rd Feb 201610:07 amRNSDirector Share Purchase
1st Feb 20167:00 amRNSNotice of Grant of Key US Patent
12th Jan 20167:00 amRNSPre-clinical data relating to exosome platform
11th Jan 20167:00 amRNSWins UK grant to advance its exosome platform
17th Dec 20157:00 amRNSReNeuron establishes Scientific Advisory Board
7th Dec 20157:00 amRNSInterim Results
4th Dec 20157:00 amRNSNon-executive Director appointment
12th Nov 20152:45 pmRNSNotification of Interim Results
34567891011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.